REFRACTORY METASTATIC COLORECTAL CANCER

Clinical trials for REFRACTORY METASTATIC COLORECTAL CANCER explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY METASTATIC COLORECTAL CANCER trials appear

Sign up with your email to follow new studies for REFRACTORY METASTATIC COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1

New hope for patients with aggressive cancers that have run out of options

Disease control Ongoing

This study is testing the safety and effectiveness of a new two-drug combination for people with advanced colorectal and other gastrointestinal cancers that have stopped responding to standard treatments. The trial combines an oral pill (vorbipiprant) with an immunotherapy drug (…

Matched conditions: REFRACTORY METASTATIC COLORECTAL CANCER

Phase: PHASE1, PHASE2 • Sponsor: Rottapharm Biotech • Aim: Disease control

Last updated Mar 25, 2026 14:09 UTC

REFRACTORY METASTATIC COLORECTAL CANCER

Get alerted when new REFRACTORY METASTATIC COLORECTAL CANCER trials appear

New hope for patients with aggressive cancers that have run out of options